Cargando…

Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer

OBJECTIVE: Colonic mucosa-associated Escherichia coli are increased in Crohn's disease (CD) and colorectal cancer (CRC). They variously haemagglutinate, invade epithelial cell lines, replicate within macrophages, translocate across M (microfold) cells and damage DNA. We investigated genes respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Prorok-Hamon, Maelle, Friswell, Melissa K, Alswied, Abdullah, Roberts, Carol L, Song, Fei, Flanagan, Paul K, Knight, Paul, Codling, Caroline, Marchesi, Julian R, Winstanley, Craig, Hall, Neil, Rhodes, Jonathan M, Campbell, Barry J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995253/
https://www.ncbi.nlm.nih.gov/pubmed/23846483
http://dx.doi.org/10.1136/gutjnl-2013-304739
_version_ 1782312848976773120
author Prorok-Hamon, Maelle
Friswell, Melissa K
Alswied, Abdullah
Roberts, Carol L
Song, Fei
Flanagan, Paul K
Knight, Paul
Codling, Caroline
Marchesi, Julian R
Winstanley, Craig
Hall, Neil
Rhodes, Jonathan M
Campbell, Barry J
author_facet Prorok-Hamon, Maelle
Friswell, Melissa K
Alswied, Abdullah
Roberts, Carol L
Song, Fei
Flanagan, Paul K
Knight, Paul
Codling, Caroline
Marchesi, Julian R
Winstanley, Craig
Hall, Neil
Rhodes, Jonathan M
Campbell, Barry J
author_sort Prorok-Hamon, Maelle
collection PubMed
description OBJECTIVE: Colonic mucosa-associated Escherichia coli are increased in Crohn's disease (CD) and colorectal cancer (CRC). They variously haemagglutinate, invade epithelial cell lines, replicate within macrophages, translocate across M (microfold) cells and damage DNA. We investigated genes responsible for these effects and their co-association in colonic mucosal isolates. DESIGN: A fosmid library yielding 968 clones was prepared in E coli EPI300-T1 using DNA from a haemagglutinating CRC isolate, and resulting haemagglutinating clones were 454-pyrosequenced. PCR screening was performed on 281 colonic E coli isolates from inflammatory bowel disease (IBD) (35 patients), CRC (21) and controls (24; sporadic polyps or irritable bowel syndrome). RESULTS: 454-Pyrosequencing of fosmids from the haemagglutinating clones (n=8) identified the afimbrial adhesin afa-1 operon. Transfection of afa-1 into E coli K-12 predictably conferred diffuse adherence plus invasion of HEp-2 and I-407 epithelial cells, and upregulation of vascular endothelial growth factor. E coli expressing afaC were common in CRC (14/21, p=0.0009) and CD (9/14, p=0.005) but not ulcerative colitis (UC; 8/21) compared with controls (4/24). E coli expressing both afaC and lpfA (relevant to M-cell translocation) were common in CD (8/14, p=0.0019) and CRC (14/21, p=0.0001), but not UC (6/21) compared with controls (2/24). E coli expressing both afaC and pks (genotoxic) were common in CRC (11/21, p=0.0015) and UC (8/21, p=0.022), but not CD (4/14) compared with controls (2/24). All isolates expressed dsbA and htrA relevant to intra-macrophage replication, and 242/281 expressed fimH encoding type-1 fimbrial adhesin. CONCLUSIONS: IBD and CRC commonly have colonic mucosal E coli that express genes that confer properties relevant to pathogenesis including M-cell translocation, angiogenesis and genotoxicity.
format Online
Article
Text
id pubmed-3995253
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39952532014-04-25 Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer Prorok-Hamon, Maelle Friswell, Melissa K Alswied, Abdullah Roberts, Carol L Song, Fei Flanagan, Paul K Knight, Paul Codling, Caroline Marchesi, Julian R Winstanley, Craig Hall, Neil Rhodes, Jonathan M Campbell, Barry J Gut Inflammatory Bowel Disease OBJECTIVE: Colonic mucosa-associated Escherichia coli are increased in Crohn's disease (CD) and colorectal cancer (CRC). They variously haemagglutinate, invade epithelial cell lines, replicate within macrophages, translocate across M (microfold) cells and damage DNA. We investigated genes responsible for these effects and their co-association in colonic mucosal isolates. DESIGN: A fosmid library yielding 968 clones was prepared in E coli EPI300-T1 using DNA from a haemagglutinating CRC isolate, and resulting haemagglutinating clones were 454-pyrosequenced. PCR screening was performed on 281 colonic E coli isolates from inflammatory bowel disease (IBD) (35 patients), CRC (21) and controls (24; sporadic polyps or irritable bowel syndrome). RESULTS: 454-Pyrosequencing of fosmids from the haemagglutinating clones (n=8) identified the afimbrial adhesin afa-1 operon. Transfection of afa-1 into E coli K-12 predictably conferred diffuse adherence plus invasion of HEp-2 and I-407 epithelial cells, and upregulation of vascular endothelial growth factor. E coli expressing afaC were common in CRC (14/21, p=0.0009) and CD (9/14, p=0.005) but not ulcerative colitis (UC; 8/21) compared with controls (4/24). E coli expressing both afaC and lpfA (relevant to M-cell translocation) were common in CD (8/14, p=0.0019) and CRC (14/21, p=0.0001), but not UC (6/21) compared with controls (2/24). E coli expressing both afaC and pks (genotoxic) were common in CRC (11/21, p=0.0015) and UC (8/21, p=0.022), but not CD (4/14) compared with controls (2/24). All isolates expressed dsbA and htrA relevant to intra-macrophage replication, and 242/281 expressed fimH encoding type-1 fimbrial adhesin. CONCLUSIONS: IBD and CRC commonly have colonic mucosal E coli that express genes that confer properties relevant to pathogenesis including M-cell translocation, angiogenesis and genotoxicity. BMJ Publishing Group 2014-05 2013-07-11 /pmc/articles/PMC3995253/ /pubmed/23846483 http://dx.doi.org/10.1136/gutjnl-2013-304739 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Inflammatory Bowel Disease
Prorok-Hamon, Maelle
Friswell, Melissa K
Alswied, Abdullah
Roberts, Carol L
Song, Fei
Flanagan, Paul K
Knight, Paul
Codling, Caroline
Marchesi, Julian R
Winstanley, Craig
Hall, Neil
Rhodes, Jonathan M
Campbell, Barry J
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title_full Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title_fullStr Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title_full_unstemmed Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title_short Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
title_sort colonic mucosa-associated diffusely adherent afac+ escherichia coli expressing lpfa and pks are increased in inflammatory bowel disease and colon cancer
topic Inflammatory Bowel Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995253/
https://www.ncbi.nlm.nih.gov/pubmed/23846483
http://dx.doi.org/10.1136/gutjnl-2013-304739
work_keys_str_mv AT prorokhamonmaelle colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT friswellmelissak colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT alswiedabdullah colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT robertscaroll colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT songfei colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT flanaganpaulk colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT knightpaul colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT codlingcaroline colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT marchesijulianr colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT winstanleycraig colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT hallneil colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT rhodesjonathanm colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer
AT campbellbarryj colonicmucosaassociateddiffuselyadherentafacescherichiacoliexpressinglpfaandpksareincreasedininflammatoryboweldiseaseandcoloncancer